AwardTape · Defense awards · Research and development · Health R&D · HT942524C0070
HT942524C0070: $1.3M definitive contract to Nushores Biosciences LLC
Nushores Biosciences LLC holds a definitive contract from Defense Health Agency with $1.3M obligated since Oct 2023, against a ceiling of $1.3M. Latest action Aug 20, 2024.
Dha sbir 2nd ph ii h2s-0068 medical research and development contract titled product development and commercialization readiness for a class of ether-based bioresorbable polyurethanes for biomedical applications.
| PIID | HT942524C0070 |
|---|---|
| Type | definitive contract |
| Company | Nushores Biosciences LLC |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $1.3M |
| Total obligated (lifetime) | $1.3M |
| Ceiling (base and all options) | $1.3M |
| Base date | Aug 20, 2024 |
| Latest action | Aug 20, 2024 |
| End date | Dec 20, 2026 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | AR |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial